RWA
Redhawk Wealth Advisors’s Myriad Genetics MYGN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-37,205
| Closed | -$710K | – | 196 |
|
2022
Q3 | $710K | Buy |
37,205
+2,525
| +7% | +$48.2K | 0.3% | 93 |
|
2022
Q2 | $630K | Buy |
34,680
+3,018
| +10% | +$54.8K | 0.29% | 96 |
|
2022
Q1 | $798K | Buy |
31,662
+15,635
| +98% | +$394K | 0.21% | 84 |
|
2021
Q4 | $442K | Buy |
16,027
+4,072
| +34% | +$112K | 0.11% | 126 |
|
2021
Q3 | $386K | Buy |
+11,955
| New | +$386K | 0.11% | 132 |
|